Phase II study of efficacy of bevacizumab plus chemotherapy in management of malignant pleural effusion in non-squamous non-small cell lung cancer patients with malignant pleural effusion (MPE) unsuccessfully controlled by tube drainage or pleurodesis (NEJ-13-2 trial)

被引：0
|
作者：
Noro, R. [1 ]
Kobayashi, K. [2 ]
Usuki, J. [3 ]
Hosomi, Y. [4 ]
Nishitsuji, M. [5 ]
Okamoto, H. [6 ]
Ando, M. [7 ]
Hino, M. [8 ,9 ,10 ]
Hagiwara, K. [11 ]
Miyanaga, A. [1 ]
Seike, M. [1 ]
Kubota, K. [1 ]
Gemma, A. [1 ]
机构：
[1] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo, Japan
[2] Saitama Med Univ, Dept Resp Med, Int Med Ctr, Hidaka, Japan
[3] Nippon Med Sch, Musashikosugi Hosp, Dept Pulm Med, Kawasaki, Kanagawa, Japan
[4] Tokyo Metropolitan Canc & Infect Dis Ctr, Komagome Hosp, Dept Thorac Oncol & Resp Med, Tokyo, Japan
[5] Ishikawa Prefectural Cent Hosp, Dept Pulm Med, Kanazawa, Ishikawa, Japan
[6] Yokohama Municipal Citizens Hosp, Dept Resp Med, Yokohama, Kanagawa, Japan
[7] Tsuboi Canc Ctr Hosp, Jizankai Med Fdn, Dept Internal Med, Fukushima, Japan
[8] Nippon Med Sch, Chiba Hokuso Hosp, Dept Pulm Med, Chiba, Japan
[9] Jichi Med Univ, Dept Pulm Med, Shimotsuke, Tochigi, Japan
[10] Nippon Med Sch, Dept Pulm Med, Chiba Hokuso Hosp, Chiba, Japan
[11] Jichi Med Univ, Dept Pulm Med, Shimotsuke, Tochigi, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
445P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer
    Chen, Yao
    Mathy, Nicholas W.
    Lu, Hongda
    MOLECULAR MEDICINE REPORTS, 2018, 17 (06) : 8019 - 8030
  • [32] Efficacy of osimertinib in patients with EGFR-mutation positive non-small cell lung cancer with malignant pleural effusion
    Kiritani, Ayu
    Amino, Yoshiaki
    Uchibori, Ken
    Akita, Takahiro
    Harutani, Yuhei
    Ogusu, Shinsuke
    Tsugitomi, Ryosuke
    Manabe, Ryo
    Ariyasu, Ryo
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    THORACIC CANCER, 2024, 15 (05) : 402 - 409
  • [33] Thoracoscopic Intrapleural Perfusion Hyperthermic Chemotherapy for Malignant Pleural Dissemination or Effusion in Non-Small Cell Lung Cancer
    Kang, Moon Chul
    Lee, Jung-Moon
    Yang, Hee Chul
    Jung, Yochun
    Jheon, Sanghoon
    Sung, Sook Whan
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S403 - S403
  • [34] Phase II study of bevacizumab (Bv) in combination with paclitaxel-carboplatin (PC) as first-line chemotherapy for nonsquamous (SQ) non-small cell lung cancer (NSCLC) with malignant pleural effusion (MPE).
    Tamiya, Motohiro
    Hirashima, Tomonori
    Tamiya, Akihiro
    Okamoto, Norio
    Suzuki, Hidekazu
    Yamadori, Tadahiro
    Morishita, Naoko
    Shiroyama, Takayuki
    Otsuka, Tomoyuki
    Kitai, Kanako
    Yasue, Tomomi
    Asami, Kazuhiro
    Minomo, Shojiro
    Sonobe, Syoko
    Nakao, Keiko
    Kawaguchi, Tomoya
    Atagi, Shinji
    Kawase, Ichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion
    Du, Nan
    Li, Xiaosong
    Li, Fang
    Zhao, Hui
    Fan, Zhongyi
    Ma, Junxun
    Fu, Yan
    Kang, Huanrong
    ONCOLOGY REPORTS, 2013, 29 (06) : 2332 - 2340
  • [36] Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
    Song, Xinyu
    Chen, Dawei
    Guo, Jun
    Kong, Li
    Wang, Haiyong
    Wang, Zhehai
    ONCOTARGETS AND THERAPY, 2018, 11 : 8421 - 8426
  • [37] A Multicenter Study of EGFR and EML4-ALK Detection in Non-Squamous, Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusion
    Shi, Xun
    Song, Zhengbo
    Yu, Xinmin
    Zhang, Yiping
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S495 - S495
  • [38] Bevacizumab for ramucirumab refractory malignant pleural effusion in non-small cell lung cancer: a case report and review of the literature
    Mori, Ryobu
    Fujimoto, Daichi
    Ito, Munehiro
    Tomii, Keisuke
    ONCOTARGET, 2017, 8 (29) : 48521 - 48524
  • [39] Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study
    Takemoto, Shinnosuke
    Fukuda, Minoru
    Yamaguchi, Hiroyuki
    Ikeda, Takaya
    Akagi, Kazumasa
    Tomono, Hiromi
    Umeyama, Yasuhiro
    Dotsu, Yosuke
    Taniguchi, Hirokazu
    Gyotoku, Hiroshi
    Senju, Hiroaki
    Kitazaki, Takeshi
    Nakatomi, Katsumi
    Nagashima, Seiji
    Fukuda, Masaaki
    Kinoshita, Akitoshi
    Soda, Hiroshi
    Mukae, Hiroshi
    THORACIC CANCER, 2020, 11 (02) : 389 - 393
  • [40] Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion
    Tamiya, Motohiro
    Tamiya, Akihiro
    Yasue, Tomomi
    Nakao, Keiko
    Omachi, Naoki
    Shiroyama, Takayuki
    Tani, Eriko
    Hamaguchi, Masanari
    Morishita, Naoko
    Suzuki, Hidekazu
    Okamoto, Norio
    Okishio, Kyoichi
    Kawaguchi, Tomoya
    Atagi, Shinji
    Hirashima, Tomonori
    ANTICANCER RESEARCH, 2016, 36 (06) : 2939 - 2944
12345